| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |